Subscribe
shutterstock_1569668848_sundry_photography
Sundry Photography / Shutterstock.com
16 December 2019AmericasRory O'Neill

Senators demand USPTO probe into Gilead allegations

The US Patent and Trademark Office (USPTO) is coming under increasing pressure to review allegations that Gilead delayed development of its latest HIV drug in order to maximise profits.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Sanders calls on USPTO to block Gilead patent extension
9 December 2019   US presidential candidate Bernie Sanders has called on the US Patent and Trademark Office to block extensions to two Gilead Sciences patents covering HIV prevention drugs including Descovy.


Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024

Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024
Unified Patent Court
‘Every CMS filing is painful’: Notes from a Unified Patent Court dispute
26 September 2024
Unified Patent Court
Interview: Klaus Grabinski, UPC Court of Appeal president
24 September 2024
Unified Patent Court
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
12 September 2024
Unified Patent Court
Does the UPC offer a fresh take on patent validity?
5 September 2024

More on this story

Americas
Sanders calls on USPTO to block Gilead patent extension
9 December 2019   US presidential candidate Bernie Sanders has called on the US Patent and Trademark Office to block extensions to two Gilead Sciences patents covering HIV prevention drugs including Descovy.

More on this story

Americas
Sanders calls on USPTO to block Gilead patent extension
9 December 2019   US presidential candidate Bernie Sanders has called on the US Patent and Trademark Office to block extensions to two Gilead Sciences patents covering HIV prevention drugs including Descovy.

More features

President Trump 2.0: Five major areas to watch
Startup CFO’s betrayal is a lesson in preparing for the worst
Sandoz lands reduced antitrust award of $70m
New president’s to-do list: Patent bills, non-competes, USPTO director?
Sanofi subsidiary fends off $450m trade secrets case
Regulatory expert joins White & Case
Teva faces $500m fine for antitrust breaches over MS drug
UK Budget: A missed opportunity?